Newgenivf Group Limited, a fertility services provider trading on Nasdaq as NIVF, disclosed crypto trading activity during 2025 in an amended registration statement filed Sept. 10, 2026. The company began investing excess treasury balances in bitcoin, ethereum, solana, and XRP as part of its capital allocation strategy, though the filing emphasized that digital asset activity was not part of its core IVF operating business.
According to the company's Form F-1/A filing, Newgenivf purchased 146,432 XRP during the year and sold the entire position, realizing $10,849 in gains on the round trip. The company also bought and sold 8.77 BTC, generating $12,569, and 8.95 ETH, which produced $223 in gains. These three assets were fully liquidated by year-end.
Solana was the only asset retained in the company's portfolio. Newgenivf held 13,000.23 SOL at Dec. 31, 2025, with a cost basis of $2,906,222 and a fair value of $1,630,827 at year-end prices, representing a $1.28 million unrealized loss. Combined with realized trading gains, the company recorded a net loss of $332,480 in other income and expense for the period.
The company's filing stated it did not mine or stake crypto, did not accept digital assets as patient payment, and conducted all trading through third-party platforms.
